Bank of Montreal
IMMX icon

Bank of Montreal’s Immix Biopharma IMMX Stock Holding History

Bank of Montreal’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$72K – 4102
2023
Q4 		$72K Buy
+10,000
New +$45.3K ﹤0.01% 3466
2023
Q1 		– Sell
-15,000
Closed -$36K – 3975
2022
Q4 		$36K Buy
+15,000
New +$20K ﹤0.01% 3605

Other funds holding IMMX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Bank of Montreal's IMMX Position: Q1 2024 in Review

Bank of Montreal sold out of Immix Biopharma (IMMX) in Q1 2024, closing a stake of 10,000 shares — an estimated $72K sold.

Bank of Montreal first reported a position in IMMX in Q4 2022 and held it in 2 quarters. The position peaked at $72K in Q4 2023. 35 funds tracked by Wall St. Rank hold IMMX as of Q1 2024.

  • Bank of Montreal reported no remaining Immix Biopharma position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 10,000 Immix Biopharma shares in Q1 2024, an estimated $72K.
  • Bank of Montreal first reported a position in Immix Biopharma in Q4 2022 and held it in 2 quarters.
  • Bank of Montreal's Immix Biopharma position peaked at $72K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.